1. Home
  2. CXW vs ZLAB Comparison

CXW vs ZLAB Comparison

Compare CXW & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CoreCivic Inc.

CXW

CoreCivic Inc.

HOLD

Current Price

$30.78

Market Cap

2.4B

Sector

Real Estate

ML Signal

HOLD

Logo Zai Lab Limited

ZLAB

Zai Lab Limited

HOLD

Current Price

$17.96

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CXW
ZLAB
Founded
1983
2013
Country
United States
China
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.0B
IPO Year
2001
2017

Fundamental Metrics

Financial Performance
Metric
CXW
ZLAB
Price
$30.78
$17.96
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
$32.00
$49.60
AVG Volume (30 Days)
1.3M
968.1K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
74.19
38.46
EPS
0.38
N/A
Revenue
$2,211,182,000.00
$460,156,000.00
Revenue This Year
$17.13
$9.75
Revenue Next Year
$5.64
$26.03
P/E Ratio
$77.32
N/A
Revenue Growth
12.72
15.33
52 Week Low
$15.74
$15.96
52 Week High
$30.77
$41.20

Technical Indicators

Market Signals
Indicator
CXW
ZLAB
Relative Strength Index (RSI) 84.86 45.85
Support Level $18.38 $16.78
Resistance Level N/A $19.41
Average True Range (ATR) 1.24 0.68
MACD 0.28 0.21
Stochastic Oscillator 97.36 55.79

Price Performance

Historical Comparison
CXW
ZLAB

About CXW CoreCivic Inc.

CoreCivic Inc is an owner and operator of private prisons and detention centers in the United States. It operates in three segments: Safety, Community, and Properties. The Community segment owns and operates residential reentry centers. The Properties segment owns properties for lease to third parties and government agencies. The vast majority of the company's revenue comes from the CoreCivic Safety segment which consists of correctional and detention facilities that are owned, or controlled via a long-term lease, and managed by the company, as well as those correctional and detention facilities owned by third parties but managed by CoreCivic.

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.

Share on Social Networks: